Home › Cancer (all types) › NCT06037681

Cannabis Use and Outcomes in Black and White Patients With Cancer

Who can join

Ages 21 to 99 · All sexes

Inclusion Criteria:

* 21 years or older
* Black or white race
* Solid tumor cancer within 3 years of enrollment
* Cannabis use of at least once a week or non cannabis use for 3 months
* experience pain but spend less than 50% in bed or chair
* Prescribed or take opioid for at least 30 days for pain
* Not pregnant or planning to become pregnant in the next 12 months
* English speaking

Exclusion Criteria:

* Lymphoma, leukemia, and melanoma
* CBD only use
* Synthetic cannabis use in past 3 months = Prescribed Medically-prescribed synthetic cannabis (e.g., dronabinol \[Marinol, Syndros\], Epidiolex)
* race other than Black or White

About the study

The goal of the observational study is to learn how black and white patients with solid tumor cancer use cannabis, opioids and tobacco. The investigators are using momentary ecological assessment through a smart phone app and surveys to assess patient-reported pain and other symptoms as to inform clinical practice and guidelines for underrepresented populations.

Sponsor: State University of New York at Buffalo · Participants: 600 · Started: Mar 30, 2023

Contact the study team

• Colleen Kilanowski, MS · Phone: 716-829-5977
• Rebecca L Ashare, BA · Phone: 716-829-2024

Official record on ClinicalTrials.gov — NCT06037681

Locations in the U.S.

Conditions

• Cancer (all types)
• Cannabis

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.